Compositions for pre-surgical nutritional supplements
US-2024189256-A1 · Jun 13, 2024 · US
US9649325B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9649325-B2 |
| Application number | US-201113053128-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 21, 2011 |
| Priority date | Mar 19, 2010 |
| Publication date | May 16, 2017 |
| Grant date | May 16, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to esterified polysaccharide osmotics, use of same, processes for synthesis of same as well as compositions containing same.
Opening claim text (preview).
What is claimed is: 1. A kit configured for the preparation of a dialysis solution, the kit comprising: a multi-chamber plastic bag comprising a first chamber and a second chamber, wherein the first chamber is separated from said second chamber by a detachable and/or breakable separation system; a solid composition comprising a starch in solid form contained in the first chamber; and a second component comprising a solvent, the second component contained in the second chamber; wherein the dialysis solution is obtained by mixing the solid composition with the second component, the solid composition then being dissolved by said solvent, wherein the solid composition is mixable with the second component after releasing and/or breaking the separation system, thus forming the dialysis solution, and wherein the starch is esterified at least partially with a citric acid or isocitric acid and wherein the obtained dialysis solution contains the starch esterified at least partially with a citric acid or isocitric acid in a total concentration of 0.001 mM to 10 M. 2. The kit according to claim 1 , wherein the average molecular weight of the starch is between 2000 and 30,000 g/mol. 3. The kit according to claim 1 , wherein the starch comprises a polysaccharide having a degree of polymerization between 10 and 170. 4. The kit according to claim 1 , wherein a 7.5 weight percent aqueous solution of the starch has an osmolarity greater than 11.9 mosm/L. 5. The kit according to claim 1 , wherein the starch comprises a polysaccharide having a degree of substitution between 0.01 and 3. 6. The kit according to claim 1 , wherein the dialysis solution is suitable for hemodialysis or peritoneal dialysis treatment. 7. The kit of claim 1 , further comprising one or more additional components, wherein the dialysis solution is obtained by mixing the solid composition with the second component and with the additional component(s).
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P27/04) · CPC title
Drugs for disorders of the blood or the extracellular fluid · CPC title
of the kidneys · CPC title
of urine or of the urinary tract, e.g. urine acidifiers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.